Slaying motor neurone disease death signals

February 26, 2016
Slaying motor neurone disease death signals
A slice through a spinal column showing the physical connection that links the brain to muscles.

Motor neurone disease may still be considered a certain and unpleasant death sentence, but researchers at The University of Queensland are testing a promising treatment option.

Professor Elizabeth Coulson, from the UQ School of Biomedical Sciences and the Queensland Brain Institute (QBI) says a very early candidate drug has led to positive results in mice with MND, a disease that diminishes the ability to move and, eventually, breathe.

"We've had encouraging positive results in MND mice, showing that we could keep dying alive for longer and delay disease onset," Professor Coulson said.

The team found a particular protein linked to MND, called p75, could be affected by the drug.

"We've triggered a cell survival-signalling pathway and blocked a cell death-signal pathway used by the p75 protein to kill dying motor neurons.

Collaborators from the University of Adelaide found that a by-product of this protein was found in high levels in people with MND, and could be measured in urine and blood.

Professor Coulson said testing showed less of this by-product in mice that received treatment, indicating that motor neuron degeneration was not being activated to the same extent.

"The drop in by-product output fitted with the idea that we were affecting the pathway in which we were interested," she said.

"This validates investigating p75 not only as a drug target, but also as a marker for the extent of motor neuron degeneration."

Professor Coulson said both the drug and the by-product could be applicable for other neuronal degenerative diseases, such as Alzheimer's disease or after a stroke.

"At this stage, the drug is a peptide and it is degraded by the body very quickly, but we're actually really encouraged that something with such poor stability displayed real potential," she said.

"I've been working on MND for almost 20 years and, if we can make this peptide stable and in the right drug form, we could be looking at an available treatment in two to 10 years.

"There are a lot of 'ifs'—one of which is that the drug might not work in humans with MND—but the mechanism of action revealed by the study, the way the works, should mean it could also be effective in Alzheimer's and general dementia by promoting cognitive enhancement as well as slowing cell degeneration."

The study is available online in the Journal of Cell Science.

Explore further: Stem cell study aids quest for motor neurone disease therapies

More information: D. Matusica et al. Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment, Journal of Cell Science (2015). DOI: 10.1242/jcs.173864

Related Stories

Stem cell discovery gives insight into motor neurone disease

February 11, 2013

A discovery using stem cells from a patient with motor neurone disease could help research into treatments for the condition. The study used a patient's skin cells to create motor neurons - nerve cells that control muscle ...

Recommended for you

Finding new clues to a sugar suspect in birth defects

June 22, 2016

Most pregnant women with well-controlled diabetes give birth to healthy children. But their babies run much higher risks of birth defects than babies born to women without diabetes, because very early in embryonic development, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.